Skip to main content

Table 3 Univariate and multivariate analysis of clinicopathologic factors affecting disease-free survival rate

From: Prognostic significance of VEGF expression in patients with bulky cervical carcinoma undergoing neoadjuvant chemotherapy

    Univariate analysis Multivariate analysis
Characteristics No. of patients 5-y DFS (%) P Relative risk (95% CI) P
Cervical tumor size      
   ≥5 cm 14 69.2 0.50 0.66 0.53a
   < 5 cm 15 80.0   (0.18 – 2.42)  
Clinical node involvement      
   Yes 11 70.6 0.49 2.30 0.39
   No 18 81.8   (0.35 – 15.10)  
Stage      
   IB2 20 73.3 0.83 0.67 0.64
   IIA 9 77.8   (0.13 – 3.58)  
SCC Ag level      
   ≥5 ng/ml 14 69.2 0.50 1.03 0.45a
   < 5 ng/ml 15 80.0   (0.95 – 1.12)  
VEGF expression      
   Negative 14 92.3 0.033 11.40 0.037
   Positive 15 60.0   (1.15 – 112.58)  
  1. a Treated as a continuous variable.